Visualitza per autor "Pizzamiglio, Sara"
Ara mostrant els elements 1-4 d 4
-
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy
Appierto, Valentina; Silvestri, Marco; Baselga Torres, Jose Manuel; Piccart, Martine; Nuciforo, Paolo Giovanni; Di Cosimo, Serena; Pizzamiglio, Sara (MDPI, 2020-02-18) -
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
Cappelletti, Vera; Silvestri, Marco; El-Abed, Sarra; Nuciforo, Paolo Giovanni; Di Cosimo, Serena; Ciniselli, Chiara Maura; Pizzamiglio, Sara (Frontiers Media, 2023-01-31) -
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab
Ligorio, Francesca; Di Cosimo, Serena; verderio, paolo; ciniselli, chiara maura; Pizzamiglio, Sara; Castagnoli, Lorenzo; Nuciforo, Paolo (Oxford University Press, 2022-12) -
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
Cosentino, Giulia; Cataldo, Alessandra; Plantamura, Ilaria; Nuciforo, Paolo Giovanni; Ciniselli, Chiara Maura; Pizzamiglio, Sara; De Cecco, Loris (Wiley, 2022-01)